98 related articles for article (PubMed ID: 18771174)
1. [The involvement of c-Abl and D40 (AF15q14/CASC5) proteins in the regulation of cell proliferation and cancer].
Bogdanov KV; Takimoto M
Tsitologiia; 2008; 50(7):590-6. PubMed ID: 18771174
[TBL] [Abstract][Full Text] [Related]
2. The protein encoded by cancer/testis gene D40/AF15q14 is localized in spermatocytes, acrosomes of spermatids and ejaculated spermatozoa.
Sasao T; Itoh N; Takano H; Watanabe S; Wei G; Tsukamoto T; Kuzumaki N; Takimoto M
Reproduction; 2004 Dec; 128(6):709-16. PubMed ID: 15579588
[TBL] [Abstract][Full Text] [Related]
3. The leukaemic oncoproteins Bcr-Abl and Tel-Abl (ETV6/Abl) have altered substrate preferences and activate similar intracellular signalling pathways.
Voss J; Posern G; Hannemann JR; Wiedemann LM; Turhan AG; Poirel H; Bernard OA; Adermann K; Kardinal C; Feller SM
Oncogene; 2000 Mar; 19(13):1684-90. PubMed ID: 10763825
[TBL] [Abstract][Full Text] [Related]
4. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle.
Welch PJ; Wang JY
Cell; 1993 Nov; 75(4):779-90. PubMed ID: 8242749
[TBL] [Abstract][Full Text] [Related]
5. Disruption of retinoblastoma protein function by coexpression of its C pocket fragment.
Welch PJ; Wang JY
Genes Dev; 1995 Jan; 9(1):31-46. PubMed ID: 7828850
[TBL] [Abstract][Full Text] [Related]
6. Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.
Ling X; Ma G; Sun T; Liu J; Arlinghaus RB
Cancer Res; 2003 Jan; 63(2):298-303. PubMed ID: 12543778
[TBL] [Abstract][Full Text] [Related]
7. Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells.
Sattler M; Pride YB; Quinnan LR; Verma S; Malouf NA; Husson H; Salgia R; Lipkowitz S; Griffin JD
Oncogene; 2002 Feb; 21(9):1423-33. PubMed ID: 11857085
[TBL] [Abstract][Full Text] [Related]
8. Targeted Knockdown of the Kinetochore Protein D40/Knl-1 Inhibits Human Cancer in a p53 Status-Independent Manner.
Urata YN; Takeshita F; Tanaka H; Ochiya T; Takimoto M
Sci Rep; 2015 Sep; 5():13676. PubMed ID: 26348410
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for the cytoskeletal association of Bcr-Abl/c-Abl.
Hantschel O; Wiesner S; Güttler T; Mackereth CD; Rix LL; Mikes Z; Dehne J; Görlich D; Sattler M; Superti-Furga G
Mol Cell; 2005 Aug; 19(4):461-73. PubMed ID: 16109371
[TBL] [Abstract][Full Text] [Related]
10. The tyrosine phosphatase TC48 interacts with and inactivates the oncogenic fusion protein BCR-Abl but not cellular Abl.
Mitra A; Sasikumar K; Parthasaradhi BV; Radha V
Biochim Biophys Acta; 2013 Jan; 1832(1):275-84. PubMed ID: 23124138
[TBL] [Abstract][Full Text] [Related]
11. p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase.
Goga A; Liu X; Hambuch TM; Senechal K; Major E; Berk AJ; Witte ON; Sawyers CL
Oncogene; 1995 Aug; 11(4):791-9. PubMed ID: 7651743
[TBL] [Abstract][Full Text] [Related]
12. Frequent expression of new cancer/testis gene D40/AF15q14 in lung cancers of smokers.
Takimoto M; Wei G; Dosaka-Akita H; Mao P; Kondo S; Sakuragi N; Chiba I; Miura T; Itoh N; Sasao T; Koya RC; Tsukamoto T; Fujimoto S; Katoh H; Kuzumaki N
Br J Cancer; 2002 Jun; 86(11):1757-62. PubMed ID: 12087463
[TBL] [Abstract][Full Text] [Related]
13. Identification of B cell adaptor for PI3-kinase (BCAP) as an Abl interactor 1-regulated substrate of Abl kinases.
Maruoka M; Suzuki J; Kawata S; Yoshida K; Hirao N; Sato S; Goff SP; Takeya T; Tani K; Shishido T
FEBS Lett; 2005 Jun; 579(14):2986-90. PubMed ID: 15893754
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells.
Sirvent A; Benistant C; Roche S
Biol Cell; 2008 Nov; 100(11):617-31. PubMed ID: 18851712
[TBL] [Abstract][Full Text] [Related]
15. Global Regulation of Differential Gene Expression by c-Abl/Arg Oncogenic Kinases.
Dong Q; Li C; Qu X; Cao C; Liu X
Med Sci Monit; 2017 May; 23():2625-2635. PubMed ID: 28555614
[TBL] [Abstract][Full Text] [Related]
16. Philadelphia chromosome-positive leukaemia: the translocated genes and their gene products.
Allen PB; Morgan GJ; Wiedemann LM
Baillieres Clin Haematol; 1992 Oct; 5(4):897-930. PubMed ID: 1308169
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the c-Abl and Bcr-Abl tyrosine kinases.
Hantschel O; Superti-Furga G
Nat Rev Mol Cell Biol; 2004 Jan; 5(1):33-44. PubMed ID: 14708008
[TBL] [Abstract][Full Text] [Related]
18. c-Abl tyrosine kinase can mediate tumor cell apoptosis independently of the Rb and p53 tumor suppressors.
Theis S; Roemer K
Oncogene; 1998 Aug; 17(5):557-64. PubMed ID: 9704921
[TBL] [Abstract][Full Text] [Related]
19. Homo- and hetero-oligomerization of the c-Abl kinase and Abelson-interactor-1.
Fan PD; Cong F; Goff SP
Cancer Res; 2003 Feb; 63(4):873-7. PubMed ID: 12591740
[TBL] [Abstract][Full Text] [Related]
20. Regulation for nuclear targeting of the Abl tyrosine kinase in response to DNA damage.
Yoshida K
Adv Exp Med Biol; 2007; 604():155-65. PubMed ID: 17695727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
